Table 1. Characteristics of studies included in this meta-analysis.
First author | Year | Location | Patient and control | Method | RASSF1A(M/U)b | pTNMa(M/U)b | Grade(M/U)b | |||
case | control | ≤ T1 | ≥ T2 | Low-grade | High-grade | |||||
Pi-Che Chen | 2011 | Taiwan | Tissue samples from 104 bladder UC patients and paired voided urinefrom 30 patients were collected (mdian age 70. 5years, range 40–92). 19 urinesamples from Age-and sex-matched non-cancer controls | QMSP | 9/21 | 3/16 | 26/56 | 16/6 | 5/29 | 37/33 |
Reza R. | 2011 | Denmark | tumor tissue from 105 patients and voided urine samples from 101paired urine samples. median age 70. 2 years (range 39–91)Urine samples werealso collected from 33 control patients (median age67. 7 years, range 30–91 years) | QMSP | 18/83 | 0/33 | 25/61 | 6/13 | - | - |
Hui-Hui Lin | 2010 | Taiwan | tissues and 100 ml preoperative urine were sampled from 57 patients.(median age 64, range 39–90) Urine specimens were also taken from 20 healthycontrols. | MSP | 37/20 | 0/20 | 25/7 | 17/8 | 16/3 | 26/12 |
Priscilla D Negraes | 2008 | Brazil | 39 archived tumor fragments and 23 washouts from bladder washingsof patients (median age of 67. 85 years, ranging from 40 to 90years) and acontrol group included 24 urinary bladder washings from patients withoutany bladder tumor history | MSP | 8/8 | 5/19 | - | - | 3/18 | 8/20 |
Sonata Jarmalaite | 2008 | Finland | Tumor tissues from 58 bladder cancer patients with a mean age of66 years (range: 37–85) and 3 healthy control tissues | MSP | 36/22 | 0/5 | 11/27 | 10/10 | 1/9 | 16/22 |
jian yu | 2007 | china | urine sediments from 132 bladder cancer patients, 23 age-matchedpatients with noncancerous urinary lesions, 6 neurologic diseases,and 7 healthy volunteers. | MSP | 47/85 | 2/34 | - | - | - | - |
DR Yates | 2006 | UK | Urine samples were obtained prospectively from 35 UC patients with a new diagnosis of UC had a median age of 75 years (range 54–92) and 34 healthy volunteers under the age of 40 years | QMSP | 18/17 | 9/25 | - | - | - | - |
Essel Dulaimi, | 2004 | USA | tumor tissue and urine from 45 patients (age, 37–85 years) Urine control specimens from 12 normal, healthy individuals and 9 patients with earlyurinary disease | MSP | 18/27 | 0/21 | 15/7 | 8/9 | 2/2 | 21/20 |
Michael W. Y | 2003 | Hong Kong | 40 bladder tumor tissues samples and 14 urine samples were collected from patients had a median age of 70 years (range 47–87) and 10 normal voidedurine sediments from age- and gender-match control | MSP | 7/7 | 0/10 | 7/29 | 10/10 | 1/9 | 16/14 |
Min-Goo Lee | 2001 | Korea | Fifty-five primary bladder carcinomas and 15 age- and gender-match normal bladder tissues were obtained from 55 bladder cancer patients and15 noncancer patients | MSP | 31/24 | 0/15 | - | - | - | - |
MSP, methylati on specific PCR; QMSP, quantitative methylation specific PCR. pTNM (p, pathologic stage; T, tumor size; N, node status; M, metastatic status) Tumor grade ≤1 was defined as low-grade, and tumor grade ≥2 was defined as high-grade.
p, pathologic stage; T, tumor size; N, node status; M, metastatic status;
RASSF1A methylated/RASSF1A unmethylated.